Nov 11, 2024, 16:57
Advancing Precision Oncology with Biomarker Discovery Through Multiplexed Tissue Imaging
Jean-Charles Soria, Senior Vice President and Oncology Therapeutic Area Head at Amgen, shared a post on LinkedIn:
”Biomarker discovery through highly multiplexed tissue imaging is a critical step for precision oncology. It identifies complex patterns in tumors, paving the way for novel predictive biomarkers and treatment approaches.”
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research
Authors: Alina Bollhagen, Bernd Bodenmiller.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 10:01
Dec 2, 2024, 09:04
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10
Dec 1, 2024, 22:10